In the last two decades new drugs that oppose the effects of vascular endothelial growth factor receptor (VEGFR), and thus angiogenesis, have considerably improved treatment of solid tumors. These anti-VEGFR drugs, however, are burdened by several side effects, particularly relevant on heart and vessels. Aim of this study was to analyze the changes in cardiovascular structure and function associated with use of anti-VEGFR drugs.
8C.04: possible role of arterial function in cancer treatment targeting vascular endothelial growth factor receptor oncologic response / P. Vallerio, M. Stucchi, A. Moreo, R. Ricotta, M. Pozzi, L. Giupponi, M. Cazzaniga, P. Meani, M. Varrenti, R. Facchetti, S. Di Bella, M.O. Giganti, G. Mancia, S. Siena, C. Giannattasio. - In: JOURNAL OF HYPERTENSION. - ISSN 1473-5598. - 33:Suppl 1(2015 Jun), pp. e111-e111. ((Intervento presentato al 25. convegno European Meeting on Hypertension and Cardiovascular (ESH) : June 12-15 tenutosi a Milano nel 2015 [10.1097/01.hjh.0000467649.08167.c3].
8C.04: possible role of arterial function in cancer treatment targeting vascular endothelial growth factor receptor oncologic response
S. SienaPenultimo
;
2015
Abstract
In the last two decades new drugs that oppose the effects of vascular endothelial growth factor receptor (VEGFR), and thus angiogenesis, have considerably improved treatment of solid tumors. These anti-VEGFR drugs, however, are burdened by several side effects, particularly relevant on heart and vessels. Aim of this study was to analyze the changes in cardiovascular structure and function associated with use of anti-VEGFR drugs.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
